他非诺喹琥珀酸盐
|
|
- CAS号:
- 106635-81-8
- 英文名:
- TAFENOQUINE SUCCINATE
- 英文别名:
- SB-252263;WR-238605;Krintafel;SB 252263AX;Wr238605 succinate;Tafenoquine Succinate;N-[2,6-Dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine;Parasite,inhibit,WR-238605,Inhibitor,Tafenoquine Succinate,Tafenoquine,WR238605,WR 238605;N4-(2,6-Dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)quinolin-8-yl)pentane-1,4-diamine succinate(1:1);8-[(4-Amino-1-methylbutyl)amino]-2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinoline succinate
- 中文名:
- 他非诺喹琥珀酸盐
- 中文别名:
- 琥珀酸他非诺喹;他非诺喹琥珀酸盐;N4-(2,6-二甲氧基-4-甲基-5-(3-(三氟甲基)苯氧基)喹啉-8-基)戊烷-1,4-二胺 琥珀酸盐
- CBNumber:
- CB82360531
- 分子式:
- C28H34F3N3O7
- 分子量:
- 581.5806696
- MOL File:
- 106635-81-8.mol
|
|
|
他非诺喹琥珀酸盐化学性质
-
熔点:
-
146-149°
-
|
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
DMSO: soluble5mg/mL (clear solution)
-
|
-
形态:
-
powder
-
|
-
颜色:
-
white to beige
-
|
他非诺喹琥珀酸盐性质、用途与生产工艺
Tafenoquine Succinate (WR 238605 Succinate) 是一种 8-氨基喹啉。Tafenoquine 作为抗疟疾预防剂。
Tafenoquine exhibits no anti-malarial activity in CYP 2D knock-out mice when dosed at their ED
100
values (3 mg/kg) established in WT mice. Tafenoquine anti-malarial activity is partially restored in humanized/CYP 2D6 knock-in mice when tested at two times its ED
100
(6 mg/kg).
他非诺喹琥珀酸盐
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-111529A | Tafenoquine Succinate | | 1 mg | 1090元 |
2024/04/30 | HY-111529A | 他非诺喹琥珀酸盐 Tafenoquine Succinate | 106635-81-8 | 5 mg | 2400元 |
106635-81-8, 他非诺喹琥珀酸盐 相关搜索:
- 医药原料药
- C24H28F3N3O3C4H6O4
- N4-(2,6-二甲氧基-4-甲基-5-(3-(三氟甲基)苯氧基)喹啉-8-基)戊烷-1,4-二胺 琥珀酸盐
- 琥珀酸他非诺喹
- 他非诺喹琥珀酸盐
- 106635-81-8
- Parasite,inhibit,WR-238605,Inhibitor,Tafenoquine Succinate,Tafenoquine,WR238605,WR 238605
- Krintafel
- TAFENOQUINE SUCCINATE; WR-238605, WR 238605, WR238605, SB-252263-AAB; SB252263-AAB; SB 252263-AAB; KRINTAFEL;
- N4-(2,6-Dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)quinolin-8-yl)pentane-1,4-diamine succinate(1:1)
- 8-[(4-Amino-1-methylbutyl)amino]-2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinoline succinate
- SB 252263AX
- SB-252263
- N-[2,6-Dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine
- Tafenoquine Succinate
- Wr238605 succinate
- Butanedioic acid, compd. with N(sup 4)-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1)
- WR-238605